1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
6524FB5CFA9268BDA65257D41001A8F24
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/white-paper-managing-healthcare-reform-winning-strategies-engaging-government-ecosystem-shapes-healthcare-policy?opendocument
18
19opendocument
203.236.253.192
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25RAS




Products & Services Quality, Compliance and Regulatory Government Affairs and Public Policy

White Paper: Key Pharma Strategies & Resource Benchmarks for Effectively Engaging the Government Ecosystem that Shapes Healthcare Policy

Whitepaper Image

ID: BEB-51


Pages/Slides: 6


Published: Pre-2016


Delivery Format: PDF


 

License Options:


Download White Paper

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
Please click on "Buy Now" to obtain the white paper on “Key Pharma Strategies & Resource Benchmarks for Effectively Engaging the Government Ecosystem that Shapes Healthcare Policy.”

Healthcare firms are increasingly finding it difficult to formulate successful business strategies owing to the stringent healthcare and reimbursement policies in the US. From deciding upon the office location of the company’s policy staff, to identifying the appropriate actions to take as a result of the knowledge gained, the government healthcare reform issue has proven to be a difficult field to navigate.

This white paper is designed to help companies to formulate a strategic approach for optimizing engagement with the ecosystem of agencies and groups that shape US healthcare guidelines and reimbursement policies. These groups include (but are not limited to) the CMS, NIH, and FDA.

Select key findings in the white paper include engagement strategy for CMS/Federal Government in benchmarked companies, FTEs responsible for managing CMS and/or agencies influencing CMS and most effective information exchange channels.

Industries Profiled:
Consulting; Biotech; Medical Device; Pharmaceutical; Diagnostic; Clinical Research; Communications


Companies Profiled:
Pharma; Biotech; Medical Device Companies